FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

17558111000001109: Doxorubicin 200mg/100ml solution for injection Cytosafe vials (Pfizer Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 25-Aug 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
60623601000001116 Doxorubicin 200mg/100ml solution for injection Cytosafe vials (Pfizer Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
60623701000001114 Doxorubicin 200mg/100ml solution for injection Cytosafe vials (Pfizer Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Doxorubicin 200mg/100ml solution for injection Cytosafe vials (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Doxorubicin 200mg/100ml solution for injection Cytosafe vials (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only true Inferred relationship Existential restriction modifier
Doxorubicin 200mg/100ml solution for injection Cytosafe vials (Pfizer Ltd) Is a Doxorubicin hydrochloride 2mg/mL injection solution 100mL vial false Inferred relationship Existential restriction modifier
Doxorubicin 200mg/100ml solution for injection Cytosafe vials (Pfizer Ltd) Has active ingredient Doxorubicin hydrochloride true Inferred relationship Existential restriction modifier
Doxorubicin 200mg/100ml solution for injection Cytosafe vials (Pfizer Ltd) Has manufactured dose form Conventional release solution for injection true Inferred relationship Existential restriction modifier
Doxorubicin 200mg/100ml solution for injection Cytosafe vials (Pfizer Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Doxorubicin 200mg/100ml solution for injection Cytosafe vials (Pfizer Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Doxorubicin 200mg/100ml solution for injection Cytosafe vials (Pfizer Ltd) Has specific active ingredient Doxorubicin hydrochloride true Inferred relationship Existential restriction modifier
Doxorubicin 200mg/100ml solution for injection Cytosafe vials (Pfizer Ltd) Has dispensed dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Doxorubicin 200mg/100ml solution for injection Cytosafe vials (Pfizer Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Doxorubicin 200mg/100ml solution for injection Cytosafe vials (Pfizer Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Doxorubicin 200mg/100ml solution for injection Cytosafe vials (Pfizer Ltd) Is a Doxorubicin 200mg/100ml solution for infusion vials false Inferred relationship Existential restriction modifier
Doxorubicin 200mg/100ml solution for injection Cytosafe vials (Pfizer Ltd) Is a Doxorubicin 200mg/100ml solution for infusion vials true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Doxorubicin 200mg/100ml solution for injection Cytosafe vials (Pfizer Ltd) 1 vial Has AMP True Doxorubicin 200mg/100ml solution for injection Cytosafe vials (Pfizer Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start